Publications by authors named "C Fiol"

The objectives of this study were to determine the social behavior response to repeated social regrouping (SR), and if social rank and the changes of social rank affect the growth rate and some metabolites and hormones linked to energy status, in "resident" replacement dairy heifers subjected to SR for 205 d. Fourteen dairy heifers (153.3 ± 16.

View Article and Find Full Text PDF

Lentiviral vectors (LVVs) play a critical role in gene delivery for gene-modified cell therapies. However, the lack of scalable LVV production methods and the high cost associated with them may limit their use. In this work, we demonstrate the optimization and development of a scalable, chemically defined, animal component-free LVV production process using adherent human embryonic kidney 293T cells in a fixed-bed bioreactor.

View Article and Find Full Text PDF

We aimed to evaluate the corporal and reproductive development, metabolic status, and behavioral patterns of resident dairy heifers subjected to social regroupings (SR). Holstein replacement heifers (153.3 ± 16.

View Article and Find Full Text PDF
Article Synopsis
  • Ruxolitinib is the first FDA-approved treatment for myelofibrosis (MF), improving symptoms but not eliminating the disease or significantly lowering mutation levels.
  • Resistance to ruxolitinib may come from various mechanisms, allowing MF cells to activate alternative survival pathways.
  • Research identified key genes related to proteasome function that are crucial for MF cell survival, suggesting that combining proteasome inhibitors like carfilzomib with ruxolitinib could be a more effective treatment strategy for MF patients.
View Article and Find Full Text PDF

Tyrosine kinase inhibitors (TKIs) targeting BCR-ABL1 have revolutionized therapy for chronic myeloid leukemia (CML), paving the way for clinical development in other diseases. Despite success, targeting leukemic stem cells and overcoming drug resistance remain challenges for curative cancer therapy. To identify drivers of kinase-independent TKI resistance in CML, we performed genome-wide expression analyses on TKI-resistant versus sensitive CML cell lines, revealing a nuclear factor-kappa B (NF-κB) expression signature.

View Article and Find Full Text PDF